ValiRx plc

VAL.L·LSE·Healthcare
Compare
0.1701+0.0101 (+6.31%)today
As of Oct 21, 11:31 AM BST · May be delayed up to 15 min · GBX

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close0.1600
Open0.1900
Day range0.15000.2100
52-week range0.12000.5500
Off day high−19.00%
Off 52-week high−69.07%
Volume259.98M
Avg. volume (3M)5.84M
Market cap2.25M
EPS (TTM)0.000000
Forward P/E0.00
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)-0.24
Shares outstanding1.32B
Short interest—
Earnings dateMay 29, 2025 (est.)
Analyst target—
Profit margin0.00%

Latest news

All VAL.L news ›
MarketScreener·Negative

EARNINGS AND TRADING: ValiRx profit slides; Ukrproduct loss narrows

The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: ---------- ValiRx PLC - London-based life science company - Reports... Biotechnology & Medical Research…

From articles in the 4Search news index.

In the news

1mentions in 30 days
1with it in the headline
Negativesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.